Insider · CIK 0001764157
Elizabeth A. Barrett
ceoofficerdirector
Files at SAGE (Sage Therapeutics, Inc.), URGN (UroGen Pharma Ltd.), ALLO (Allogene Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | UTender of shares Common Stock | -3,000 | - | - | 0 | Jul 31, 2025 |
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -21,500 | - | - | 0 | Jul 31, 2025 |
| Jul 28, 2025 | URGN UroGen Pharma Ltd. | AGrant or award Performance Stock Unitsderivative | +87,615 | $0.00 | $0 | 87,615 | Jul 30, 2025 |
| Jun 18, 2025 | ALLO Allogene Therapeutics, Inc. | AGrant or award Restricted Stock Unitderivative | +95,400 | $0.00 | $0 | 95,400 | Jun 23, 2025 |
| Jun 11, 2025 | SAGE Sage Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +21,500 | $0.00 | $0 | 21,500 | Jun 13, 2025 |
| Jan 31, 2025 | URGN UroGen Pharma Ltd. | AGrant or award Restricted Stock Unitsderivative | +96,377 | $0.00 | $0 | 96,377 | Feb 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.